Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy

被引:0
|
作者
Omer Jamy
Sankalp Arora
Ruby Meredith
Donna Salzman
Antonio Di Stasi
Kentaro Minagawa
Shin Mineishi
Ayman Saad
机构
[1] University of Alabama at Birmingham,Division of Hematology and Oncology, Department of Medicine
[2] University of Alabama at Birmingham,Department of Internal Medicine
[3] University of Alabama at Birmingham,Department of Radiation Oncology
[4] Pennsylvania State University,Division of Hematology and Oncology, Department of Medicine
[5] Ohio State University,Division of Hematology and Oncology, Department of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1597 / 1599
页数:2
相关论文
共 50 条
  • [1] Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy
    Jamy, Omer
    Arora, Sankalp
    Meredith, Ruby
    Salzman, Donna
    Di Stasi, Antonio
    Minagawa, Kentaro
    Mineishi, Shin
    Saad, Ayman
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1597 - 1599
  • [2] A Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Older Patients Using Fludarabine and Total Body Irradiation
    Jamy, Omer
    Arora, Sankalp
    Meredith, Ruby
    Salzman, Donna
    Di Stasi, Antonio
    Di Stasi, Antonio
    Minagawa, Kentaro
    Mineishi, Shin
    Saad, Ayman
    BLOOD, 2021, 138
  • [3] A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).
    Jamy, Omer Hassan
    Salzman, Donna E.
    Di Stasi, Antonio
    Innis-Shelton, Racquel
    Luciano, Costa
    Lamb, Lawrence S.
    Mineishi, Shin
    Saad, Ayman A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Stelljes, M
    Bornhauser, M
    Kroger, M
    Beyer, J
    Sauerland, MC
    Heinecke, A
    Berning, B
    Scheffold, C
    Silling, G
    Buchner, T
    Neubauer, A
    Fauser, AA
    Ehninger, G
    Berdel, WE
    Kienast, J
    BLOOD, 2005, 106 (09) : 3314 - 3321
  • [5] Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leukemia Undergoing Myeloablative Allogeneic Transplantation
    Hickey, Cindy Lynn
    Kim, Haesook T.
    Ho, Vincent T.
    Nikiforow, Sarah
    Gooptu, Mahasweta
    Koreth, John
    Ritz, Jerome
    Romee, Rizwan
    Alyea, Edwin P., III
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey
    BLOOD, 2019, 134
  • [6] Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
    Sebastian Giebel
    Myriam Labopin
    Gerard Socié
    Mahmoud Aljurf
    Urpu Salmenniemi
    Hélène Labussière-Wallet
    Micha Srour
    Nicolaus Kröger
    Mohsen Al Zahrani
    Bruno Lioure
    Péter Reményi
    Mutlu Arat
    Jean Henri Bourhis
    Grzegorz Helbig
    Abdelghani Tbakhi
    Edouard Forcade
    Anne Huynh
    Eolia Brissot
    Alexandros Spirydonidis
    Bipin N. Savani
    Zinaida Peric
    Arnon Nagler
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 506 - 513
  • [7] Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
    Giebel, Sebastian
    Labopin, Myriam
    Socie, Gerard
    Aljurf, Mahmoud
    Salmenniemi, Urpu
    Labussiere-Wallet, Helene
    Srour, Micha
    Kroeger, Nicolaus
    Al Zahrani, Mohsen
    Lioure, Bruno
    Remenyi, Peter
    Arat, Mutlu
    Bourhis, Jean Henri
    Helbig, Grzegorz
    Tbakhi, Abdelghani
    Forcade, Edouard
    Huynh, Anne
    Brissot, Eolia
    Spirydonidis, Alexandros
    Savani, Bipin N.
    Peric, Zinaida
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (05) : 506 - 513
  • [8] Allogeneic Hematopoietic Stem Cell Transplantation Using An Intravenous Busulfan Based Myeloablative Conditioning without Total Body Irradiation for Pediatric Patients with Acute Lymphoblastic Leukemia
    Goussetis, Eugene
    Paisiou, Anna
    Peristeri, Ioulia
    Kitra, Vassiliki
    Vessalas, George
    Dimopoulou, Maria N.
    Baltathakis, Ioannis
    Graphakos, Stelios
    BLOOD, 2010, 116 (21) : 1459 - 1459
  • [9] Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia
    F Zohren
    A Czibere
    I Bruns
    R Fenk
    T Schroeder
    T Gräf
    R Haas
    G Kobbe
    Bone Marrow Transplantation, 2009, 44 : 785 - 792
  • [10] Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia
    Zohren, F.
    Czibere, A.
    Bruns, I.
    Fenk, R.
    Schroeder, T.
    Graef, T.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2009, 44 (12) : 785 - 792